• Medinotec posted net income of $794,502 for fiscal 2026, down $1.36 million from fiscal 2025 as operating expenses climbed.
• Revenue rose 7% to $9.73 million, driven by higher distribution agreement sales outside the United States, particularly in South Africa.
• Gross profit increased 6% to $5.13 million while gross margin held steady at 53%, despite an inventory obsolescence provision.
• Operating expenses jumped to $4.03 million from $1.63 million, led by selling expenses of $1.49 million tied to South Africa distributor support costs.
• Management expects the fiscal 2027 launch of OutFlo in the United States to support growth, alongside continued expansion of South Africa distribution.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medinotec Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001663577-26-000175), on May 28, 2026, and is solely responsible for the information contained therein.